Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs

by Pangaea Biotech

CANCER Research Technology (CRT), the development and commercialisation arm of Cancer Research UK – has entered into a license agreement with Pangaea Biotech to develop p21-activated kinase (PAK) in...

Read more

DiaCarta and Pangaea Biotech Join Forces to Launch Non-Invasive Tests to Detect Genetic Mutations in Blood from Cancer Patients

by Pangaea Biotech

This agreement gives Pangaea access to the experience of DiaCarta, a leader in development and commercialization of personalized diagnostic tools, while DiaCarta stands to benefit from that of an inte...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Some regions of the human genome conside...

by Universitat de Barcelona

Many repetitive regions of the genome have been considered “junk DNA...

Photos Stream